Search research articles
Contact Us
Filters
Showing results (471-480 of 488) with videos related to
Page
of 49
Sort By:
Blood Neoplasia
|
December 24, 2025
Ipilimumab with and without nivolumab in patients with classic Hodgkin lymphoma with progression after PD-1 blockade
Reid W Merryman, Justin Kline, Robert A Redd, et al.
Blood Advances
|
October 31, 2025
A Retrospective Study of Treatment and Outcomes in Synchronous Systemic and Central Nervous System Large B-cell Lymphoma
J Erika Haydu, Robert A Redd, Matthew M Lei, et al.
Blood
|
April 7, 2019
PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation
Philippe Armand, Yi-Bin Chen, Robert A Redd, et al.
Blood Advances
|
April 3, 2025
Characteristics and outcomes of patients with double refractory and double exposed chronic lymphocytic leukemia
James T Yoon, Yinglu Zhou, Mariia Mikhaleva, et al.
Annals of Hematology
|
October 18, 2023
A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma
Reid W Merryman, Robert A Redd, Arnold S Freedman, et al.
The Journal of Allergy and Clinical Immunology
|
April 9, 2017
IL-10 overexpression predisposes to invasive aspergillosis by suppressing antifungal immunity
Cristina Cunha, Samuel M Gonçalves, Cláudio Duarte-Oliveira, et al.
Annals of Hematology
|
July 25, 2021
Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study
Won Seog Kim, Yasuhiro Oki, Seok Jin Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2019
Randomized Phase III Study of Alisertib or Investigator's Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma
Owen A O'Connor, Muhit Özcan, Eric D Jacobsen, et al.
Blood Advances
|
January 10, 2020
PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation
Matthew J Frigault, Philippe Armand, Robert A Redd, et al.
Blood
|
September 2, 2020
Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma
Gabriel K Griffin, Jason L Weirather, Margaretha G M Roemer, et al.
Page
of 49
Search research articles
Search
Showing results (471-480 of 488) with videos related to
Sort By:
Page
of 49
Blood Neoplasia
|
December 24, 2025
Ipilimumab with and without nivolumab in patients with classic Hodgkin lymphoma with progression after PD-1 blockade
Reid W Merryman, Justin Kline, Robert A Redd, et al.
Blood Advances
|
October 31, 2025
A Retrospective Study of Treatment and Outcomes in Synchronous Systemic and Central Nervous System Large B-cell Lymphoma
J Erika Haydu, Robert A Redd, Matthew M Lei, et al.
Blood
|
April 7, 2019
PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation
Philippe Armand, Yi-Bin Chen, Robert A Redd, et al.
Blood Advances
|
April 3, 2025
Characteristics and outcomes of patients with double refractory and double exposed chronic lymphocytic leukemia
James T Yoon, Yinglu Zhou, Mariia Mikhaleva, et al.
Annals of Hematology
|
October 18, 2023
A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma
Reid W Merryman, Robert A Redd, Arnold S Freedman, et al.
The Journal of Allergy and Clinical Immunology
|
April 9, 2017
IL-10 overexpression predisposes to invasive aspergillosis by suppressing antifungal immunity
Cristina Cunha, Samuel M Gonçalves, Cláudio Duarte-Oliveira, et al.
Annals of Hematology
|
July 25, 2021
Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study
Won Seog Kim, Yasuhiro Oki, Seok Jin Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2019
Randomized Phase III Study of Alisertib or Investigator's Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma
Owen A O'Connor, Muhit Özcan, Eric D Jacobsen, et al.
Blood Advances
|
January 10, 2020
PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation
Matthew J Frigault, Philippe Armand, Robert A Redd, et al.
Blood
|
September 2, 2020
Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma
Gabriel K Griffin, Jason L Weirather, Margaretha G M Roemer, et al.
Page
of 49